emerging tech investing Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
emerging tech investing DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
emerging tech investing DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
emerging tech investing DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
emerging tech investing DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
emerging tech investing DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence Scientist to Accelerate our Innovation in Healthcare
emerging tech investing Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
emerging tech investing Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
emerging tech investing DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services
QIMC Highlights Technical Advisory Role on First Atlas Matane Natural Hydrogen Project Following Quebec Parliamentary Committee Appearance
